When COVID-19 vaccines first became available, Native Americans acted swiftly and with determination to get their shots. Yet, tribal health officials said, they eventually ran up against the challenges that broadly stalled the U.S. vaccination campaign.

Rucaparib monotherapy significantly extended progression-free survival compared with placebo as first-line maintenance treatment for women with ovarian cancer, according to data from a phase 3 clinical trial.

Collaboration among many parties enabled the Phoenix Bioscience Core to become a reality. Guy Reed, MD, MS, dean of the UArizona College of Medicine – Phoenix, is quoted.

The annual event features Mel and Enid Zuckerman College of Public Health student research on sustainable health programs and public health workforce resilience.

Ann-Marie Alameddin led efforts to secure hospital funding, expand telepharmacy in small rural hospitals and develop grant-funded programs.

Rattlesnakes are officially out and about in southern Arizona, and the UArizona Poison and Drug Information Center is reminding you to be aware of your surroundings on your daily hike or walk.

Treatment with the low-dose painkiller ketamine eased uncontrollable body movements in patients with Parkinson’s disease, according to results from a Phase 2 study sponsored by PharmaTher. Scott Sherman, MD, PhD, director of the Movement Disorders Center and an associate professor of neurology at the College of Medicine – Tucson was the study's principal investigator. This content originated with a Health Sciences news release.

Lily Collins, an actress starring in Emily in Paris, opened up about how her character's fashion choices on the hit Netflix series landed her in the doctor's office every week and that she needed extra support in her shoes to make wearing heels for seemingly hours on end more bearable. Information about the risks associated with high heel pain from the University of Arizona Health Sciences in 2015 is cited.

Sandra Kurtin, PhD, ANP-C, AOCN, a hematology/oncology nurse practitioner at the UArizona Cancer Center, outlines the pathophysiology, risks, prognosis, and challenges in patients with myelodysplastic syndromes, as well as therapeutic options and the multidisciplinary management strategies for common adverse events in MDS.

The Phoenix Bioscience Core is home to BacVax, which uses molecular genetics to study Haemophilus influenzae, a common cause of ear infections. It was founded by Terrence Stull, MD, a professor at the University of Arizona College of Medicine – Phoenix, who moved the startup from the College of Medicine – Phoenix to the PBC in July 2021.